In conclusion, our integrated analyses suggested that APOBEC3B and APOBEC3C expression patterns were correlated with ER status and clinical outcome, providing an additional implication that these two genes may contribute to mutation profile and clinical outcome in breast cancer subtypes. Here, APOBEC3C is linked to breast cancer.